| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 170.09B | 165.71B | 168.56B | 159.02B | 145.74B | 116.67B |
| Gross Profit | 22.55B | 22.66B | 22.38B | 20.47B | 13.79B | 7.74B |
| EBITDA | 20.81B | 21.01B | 21.91B | 20.32B | 15.57B | 10.38B |
| Net Income | 6.17B | 8.66B | 6.50B | 5.78B | 518.00M | -2.08B |
Balance Sheet | ||||||
| Total Assets | 150.13B | 158.63B | 154.55B | 161.22B | 162.90B | 156.16B |
| Cash, Cash Equivalents and Short-Term Investments | 30.51B | 37.12B | 31.57B | 39.08B | 31.05B | 30.68B |
| Total Debt | 24.61B | 33.61B | 27.02B | 40.29B | 44.88B | 46.11B |
| Total Liabilities | 62.80B | 68.30B | 64.60B | 77.97B | 84.47B | 79.24B |
| Stockholders Equity | 84.75B | 88.68B | 87.34B | 80.71B | 75.60B | 74.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.00B | 9.41B | 14.98B | 6.39B | -14.97B |
| Operating Cash Flow | 0.00 | 17.63B | 16.78B | 20.37B | 14.05B | 3.71B |
| Investing Cash Flow | 0.00 | -4.94B | -7.58B | 1.59B | -8.99B | -20.11B |
| Financing Cash Flow | 0.00 | -2.73B | -18.35B | -8.80B | -7.62B | 3.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥243.62B | 8.29 | ― | 3.36% | 4.89% | 44.89% | |
78 Outperform | ¥70.71B | 6.56 | 8.48% | 4.59% | -1.69% | 38.42% | |
74 Outperform | ¥543.49B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
70 Outperform | ¥425.59B | 12.15 | ― | 1.60% | -0.11% | -21.86% | |
68 Neutral | ¥210.15B | 21.03 | ― | 4.77% | -3.95% | -13.75% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥400.87B | -20.09 | 3.70% | 3.42% | 4.24% | 39.02% |